Overexpression of microRNA-141 relieves chronic constriction injury-induced neuropathic pain via targeting high-mobility group box 1

International Journal of Molecular Medicine

Volumn 36, Issue 5, 2015, Pages 1433-1439

  Zhang, Jizheng ^a   Zhang, Hua ^a   Zi, Tingting ^b  

^a TIANJIN HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chronic constriction injury; High mobility group box 1; MicroRNA 141; Neuropathic pain

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA 141; HBP1 PROTEIN, RAT; MICRORNA;

3' UNTRANSLATED REGION; ADULT; ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HYPERALGESIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; ANIMAL; GENETICS; INTRASPINAL DRUG ADMINISTRATION; LENTIVIRINAE; LIGATION; METABOLISM; NEURALGIA; PAIN THRESHOLD; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; CONSTRICTION; GANGLIA, SPINAL; HMGB1 PROTEIN; HYPERALGESIA; INJECTIONS, SPINAL; LENTIVIRUS; MALE; MICRORNAS; NEURALGIA; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84945380511     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2342     Document Type: Article

References (51)

1. Sorge RE, Trang T, Dorfman R, Smith SB, Beggs S, Ritchie J, Austin JS, Zaykin DV, Vander Meulen H, Costigan M, et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med. 18: 595 599, 2012.
2. Neville A, Peleg R, Singer Y, Sherf M, and Shvartzman P. Chronic pain: A population based study. Isr Med Assoc J. 10: 676 680, 2008.
3. Baron R. Peripheral neuropathic pain: From mechanisms to symptoms. Clin J Pain 16 (Suppl): S12 S20, 2000.
4. Dimitroulas T, Duarte RV, Behura A, Kitas GD, and Raphael JH. Neuropathic pain in osteoarthritis: A review of pathophysi-ological mechanisms and implications for treatment. Semin Arthritis Rheum. 44: 145 154, 2014.
5. Phillips JR, Hopwood B, Arthur C, Stroud R, and Toms AD. The natural history of pain and neuropathic pain after knee replacement: A prospective cohort study of the point prevalence of pain and neuropathic pain to a minimum three year follow up. Bone Joint J 96 B: 1227 1233, 2014.
6. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 152: 14 27, 2011.
7. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116: 281 297, 2004.
8. Winter J, Jung S, Keller S, Gregory RI, and Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 11: 228 234, 2009.
9. Mendell JT, and Olson EN. MicroRNAs in stress signaling and human disease. Cell. 148: 1172 1187, 2012.
10. Ranganathan K, and Sivasankar V. MicroRNAs Biology and clinical applications. J Oral Maxillofac Pathol. 18: 229 234, 2014.
11. Sakai A, and Suzuki H. Emerging roles of microRNAs in chronic pain. Neurochem Int. 77: 58 67, 2014.
12. von Schack D, Agostino MJ, Murray BS, Li Y, Reddy PS, Chen J, Choe SE, Strassle BW, Li C, Bates B, et al. Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain. PLoS One. 6: e17670, 2011.
13. Aldrich BT, Frakes EP, Kasuya J, Hammond DL, and Kitamoto T. Changes in expression of sensory organ specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation. Neuroscience. 164: 711 723, 2009.
14. Favereaux A, Thoumine O, Bouali Benazzouz R, Roques V, Papon MA, Salam SA, Drutel G, Léger C, Calas A, Nagy F, et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR. 103: Role in pain. EMBO J. 30: 3830 3841, 2011.
15. Tan Y, Yang J, Xiang K, Tan Q, and Guo Q. Suppression of microRNA 155 attenuates neuropathic pain by regulating SOCS1 signalling pathway. Neurochem Res. 40: 550 560, 2015.
16. Andersson U, Erlandsson Harris H, Yang H, and Tracey KJ. HMGB1 as a DNA binding cytokine. J Leukoc Biol. 72: 1084 1091, 2002.
17. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48: 971 981, 2003.
18. Andersson U, and Tracey KJ. HMGB1 in sepsis. Scand J Infect Dis. 35: 577 584, 2003.
19. Oppenheim JJ, and Yang D. Alarmins: Chemotactic activators of immune responses. Curr Opin Immunol. 17: 359 365, 2005.
20. Genevay S, Finckh A, Payer M, Mezin F, Tessitore E, Gabay C, and Guerne PA. Elevated levels of tumor necrosis factor alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine. 33: 2041 2046, 2008.
21. McCarron RF, Wimpee MW, Hudkins PG, and Laros GS. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low back pain. Spine. 12: 760 764, 1987.
22. Vallejo R, Tilley DM, Vogel L, and Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract. 10: 167 184, 2010.
23. Chacur M, Milligan ED, Gazda LS, Armstrong C, Wang H, Tracey KJ, Maier SF, and Watkins LR. A new model of sciatic inflammatory neuritis (SIN): Induction of unilateral and bilateral mechanical allodynia following acute unilateral peri sciatic immune activation in rats. Pain. 94: 231 244, 2001.
24. Shibasaki M, Sasaki M, Miura M, Mizukoshi K, Ueno H, Hashimoto S, Tanaka Y, and Amaya F. Induction of high mobility group box 1 in dorsal root ganglion contributes to pain hyper-sensitivity after peripheral nerve injury. Pain. 149: 514 521, 2010.
25. Feldman P, Due MR, Ripsch MS, Khanna R, and White FA. The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J Neuroinflammation. 9: 180, 2012.
26. Otoshi K, Kikuchi S, Kato K, Sekiguchi M, and Konno S. Anti HMGB1 neutralization antibody improves pain related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats. Spine. 36: E692 E698, 2011.
27. Chen HP, Zhou W, Kang LM, Yan H, Zhang L, Xu BH, and Cai WH. Intrathecal miR 96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury. Neurochem Res. 39: 76 83, 2014.
28. Bennett GJ, and Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33: 87 107, 1988.
29. Yaksh TL, and Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17: 1031 1036, 1976.
30. Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53: 55 63, 1994.
31. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32: 77 88, 1988.
32. Zhang H, Cang CL, Kawasaki Y, Liang LL, Zhang YQ, Ji RR, and Zhao ZQ. Neurokinin 1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: A novel pathway for heat hyperalgesia. J Neurosci. 27: 12067 12077, 2007.
33. Maeda T, Ozaki M, Kobayashi Y, Kiguchi N, and Kishioka S. HMGB1 as a potential therapeutic target for neuropathic pain. J Pharmacol Sci. 123: 301 305, 2013.
34. Gong Q, Lu Z, Huang Q, Ruan L, Chen J, Liang Y, Wang H, Yue Y, and Feng S. Altered microRNAs expression profiling in mice with diabetic neuropathic pain. Biochem Biophys Res Commun. 456: 615 620, 2015.
35. Norcini M, Sideris A, Martin Hernandez LA, Zhang J, Blanck TJ, and Recio Pinto E: An approach to identify microRNAs involved in neuropathic pain following a peripheral nerve injury. Front Neurosci 8 266 2014.
36. Im YB, Jee MK, Jung JS, Choi JI, Jang JH, and Kang SK. miR23b ameliorates neuropathic pain in spinal cord by silencing NADPH oxidase 4. Antioxid Redox Signal. 16: 1046 1060, 2012.
37. Im YB, Jee MK, Choi JI, Cho HT, Kwon OH, and Kang SK. Molecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord. Cell Death Dis. 3: e426, 2012.
38. Willemen HL, Huo XJ, Mao Ying QL, Zijlstra J, Heijnen CJ, and Kavelaars A. MicroRNA 124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation. 9: 143, 2012.
39. Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z, Ding J, Jia L, and Yuan W. Increased miR 195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury. Glia. 61: 504 512, 2013.
40. Zhou X, Xia Y, Su J, and Zhang G. Down regulation of miR 141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell Physiol Biochem. 33: 1003 1012, 2014.
41. Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y, Yu T, Gong L, Li S, Xiao B, and Zou QM. MicroRNA 141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcrip-Tional co activator with PDZ binding motif, TAZ. Cell Death Dis. 6: e1623, 2015.
42. Sipert CR, Morandini AC, Dionísio TJ, Machado MA, Oliveira SH, Campanelli AP, Kuo WP, and Santos CF: In vitro regulation of CCL3 and CXCL12 by bacterial by products is dependent on site of origin of human oral fibroblasts. J Endod 40 95-100 2014.
43. Huang Z, Shi T, Zhou Q, Shi S, Zhao R, Shi H, Dong L, Zhang C, Zeng K, Chen J, et al. miR 141 Regulates colonic leukocytic traf-ficking by targeting CXCL12β during murine colitis and human Crohn's disease. Gut. 63: 1247 1257, 2014.
44. Lam WY, Yeung AC, Ngai KL, Li MS, To KF, Tsui SK, and Chan PK. Effect of avian influenza A H5N1 infection on the expression of microRNA 141 in human respiratory epithelial cells. BMC Microbiol. 13: 104, 2013.
45. Ren PC, Zhang Y, Zhang XD, An LJ, Lv HG, He J, Gao CJ, and Sun XD. High mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Res Bull. 88: 332 337, 2012.
46. Nakamura Y, Morioka N, Abe H, Zhang FF, Hisaoka Nakashima K, Liu K, Nishibori M, and Nakata Y. Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box 1. PLoS One. 8: e73640, 2013.
47. Tong W, Wang W, Huang J, Ren N, Wu SX, and Li YQ. Spinal high mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochem Biophys Res Commun. 395: 572 576, 2010.
48. Ma YQ, Chen YR, Leng YF, and Wu ZW. Tanshinone IIA downregulates HMGB1 and TLR4 expression in a spinal nerve ligation model of neuropathic pain. Evid Based Complement Alternat Med. 2014: 639563, 2014.
49. He Z, Guo Q, Xiao M, He C, and Zou W. Intrathecal lentivirus mediated transfer of interleukin 10 attenuates chronic constriction injury induced neuropathic pain through modulation of spinal high mobility group box 1 in rats. Pain Physician. 16: E615 E625, 2013.
50. Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang Y, Wang Y, Zhao W, and Wang W. miR 22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1 mediated autophagy. Tumour Biol. 35: 7025 7034, 2014.
51. Lu F, Zhang J, Ji M, Li P, Du Y, Wang H, Zang S, Ma D, Sun X, and Ji C. miR 181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl 1. Int J Oncol. 45: 383 392, 2014.